mountaineer: impact of genomic alterations on tucatinib plus trastuzumab activity in mcrc
Published 9 months ago • 97 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
0:56
mountaineer results: trastuzumab and tucatinib for her2 mcrc
-
2:23
mountaineer-02: tucatinib in previously treated her2 gastric cancer
-
2:13
actionable genomic alterations in rcc
-
1:09
ask unmc! does everyone suffering from carbon monoxide poisoning need hyperbaric oxygen?
-
12:16
back to the track and field - return to sports after cartilage repair
-
1:52
balance & mortality
-
2:56
randomised trials “instrumental” in future research of tricuspid valve repair
-
38:53
technological changes in a period of trouble and mutation: middle and early bronze age cyclades
-
1:54
epicks: changes in hypoxia and possible association with acute mountain sickness
-
1:28
regional perfusion therapy | montefiore einstein center for cancer care
-
8:58
escorted canadian rockies & icy glaciers with vip carriage onboard rocky mountaineer train
-
17:16
usc discussion: current landscape of temporary mechanical circulatory support technology
-
2:25
heart to heart: sudden cardiac emergencies in avid exercisers and athletes
-
1:45
physicians demonstrate tallahassee memorial's monarch™ robotic bronchoscopy platform
-
6:00
unmet needs in rehabilitation research for multiple sclerosis
-
0:31
montefiore - neurological surgery: conjoined twins, brains intertwined
-
2:50
grateful patient series: colleen johnson, dr. toman & dr. tabor